Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifekalant vs amiodarone for maintenance of sinus rhythm after AF ablation with valve replacement
ChiCTR2000039611Phase 4Recruiting
- Sponsor
- Department of Cardiovascular Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Atrial fibrillation (AFib) comparing nifekalant with Control: amiodarone (2 arms). Primary endpoint: Maintenance of sinus rhythm after radiofrequency ablation therapy for atrial fibrillation concomitant with valve replacement surgery. Started Dec 2020; status: recruiting.
02
Drugs
nifekalantamiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2000039611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039611.